IMNN
Imunon, Inc. - Common Stock (IMNN)
$91
About Imunon, Inc. - Common Stock (IMNN)
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Details
Daily high
$0.98
Daily low
$0.88
Price at open
--
52 Week High
$4.38
52 Week Low
$0.81
Market cap
5.1M
Dividend yield
-
Volume
17
Avg. volume
120,093
P/E ratio
-.23
Imunon, Inc. - Common Stock News
Details
Daily high
$0.98
Daily low
$0.88
Price at open
--
52 Week High
$4.38
52 Week Low
$0.81
Market cap
5.1M
Dividend yield
-
Volume
17
Avg. volume
120,093
P/E ratio
-.23